论文部分内容阅读
为了观察恩再适治疗偏头痛的临床效果和安全性。我们观察了恩再适对80例偏头痛患者的治疗效果。80例偏头痛患者均依照中国六城市神经系统流行病学调查协作组制定的偏头痛诊断标准选取,其中恩再适组40例,对照组40例。所有患者发病均在6个月以上,每个月至少发作2次。神经系统检查
To observe the clinical effect and safety of enoxaparin in the treatment of migraine. We observed the effect of enoxaparin in the treatment of 80 migraine sufferers. Eighty migraineurs were selected according to the diagnostic criteria for migraine developed by the collaborative group of neurological epidemiology in six cities of China, among which En-Zui-Dai group (40 cases) and control group (40 cases). All patients were more than 6 months of onset, at least 2 times per month. Neurological examination